Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,078 | -29,462 | -169,590 | -83,513 | -57,075 |
| Depreciation Amortization | 41,006 | 20,544 | 92,712 | 69,953 | 47,711 |
| Income taxes - deferred | N/A | N/A | -200 | 24 | 24 |
| Accounts receivable | 5,483 | 19,729 | 11,009 | 16,966 | 13,291 |
| Accounts payable and accrued liabilities | 892 | -1,764 | N/A | -7,005 | -4,337 |
| Other Working Capital | -53 | 6,673 | 22,268 | 1,845 | 971 |
| Other Operating Activity | -5,427 | -16,520 | 27,300 | -21,160 | -21,371 |
| Operating Cash Flow | $-9,177 | $-800 | $-16,501 | $-22,890 | $-20,786 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -3 | -984 | -964 | -949 |
| Net Acquisitions | N/A | N/A | -583 | -583 | -583 |
| Investing Cash Flow | $-3 | $-3 | $-1,567 | $-1,547 | $-1,532 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -1,000 | -1,000 | N/A |
| Debt Repayment | -12,854 | -12,835 | -20,483 | -20,456 | -14,939 |
| Common Stock Issued | N/A | N/A | 19,814 | 18,303 | 11,353 |
| Other Financing Activity | 0 | 0 | -23 | -24 | -1,024 |
| Financing Cash Flow | $-12,854 | $-12,835 | $-1,692 | $-3,177 | $-4,610 |
| Beginning Cash Position | 36,375 | 36,375 | 56,135 | 56,135 | 56,135 |
| End Cash Position | 14,341 | 22,737 | 36,375 | 28,521 | 29,207 |
| Net Cash Flow | $-22,034 | $-13,638 | $-19,760 | $-27,614 | $-26,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,177 | -800 | -16,501 | -22,890 | -20,786 |
| Capital Expenditure | -3 | -3 | -984 | -964 | -949 |
| Free Cash Flow | -9,180 | -803 | -17,485 | -23,854 | -21,735 |